James R. Staiger


Corporate, M&A, and Securities Practice

James Staiger's practice focuses on advising clients in mergers and acquisitions, private equity, and venture capital transactions along with general corporate, corporate governance, and contract matters, including:

  • Private equity transactions
  • Cross-border transactions
  • Corporate divestitures
  • Corporate finance and securities laws matters

As noted, James has significant experience handling private equity transactions, representing both the target company and the private equity firm.

Co-Lead, Life Sciences Industry Group

While James represents clients in business transactions in many industries, he has a niche practice representing life science companies engaged in the development, manufacture, sale, and distribution of pharmaceutical, biotechnology, and medical device products. Existing clients routinely refer other life science companies based around the globe to James for his extensive experience handling matters in these industries.

Additional Professional Credentials

James formerly practiced with Arthur Andersen as a certified public accountant (“CPA”) in the manufacturing division, working with pharmaceutical clients such as Merck. He has a master's degree in business administration (“MBA”) with a concentration in finance.

Outside the Firm

James is active in the Southern New Jersey Chapter of the Juvenile Diabetes Research Foundation.

James is a 2nd Degree Black Belt in Tae Kwon Do and trains in Hapkido (self-defense using joint locks, grappling, and throwing techniques). He also trains in Krav Maga.


  • Numerous private equity firms, in acquisition and divestment transactions (including the acquisition and divestment of platform companies as well as tuck-in transactions).
  • Many licensing transactions (involving new drug discovery) on behalf of numerous multinational pharmaceutical companies (including involving major U.S. universities).
  • Numerous pharmaceutical companies, in drug product acquisitions, in-licensing transactions, and all aspects of general corporate matters.
  • Jointly represented a major private equity fund and the former senior management team of a pharmaceutical company in the creation of a new pharmaceutical company by means of an acquisition of the entire legacy drug business from one of the so-called ”big pharma” companies.
  • A multinational pharmaceutical company, in the acquisition of an oncology product sold in the United States, Canada, Mexico, and 10 countries in Europe.
  • Several venture investment transactions on behalf of pharmaceutical companies based around the globe.
  • Represented a U.S. subsidiary of a non-U.S. parent (which non-U.S. parent trades publicly on a securities exchange within the non-U.S. jurisdiction) in a private placement offering of shares for hundreds of millions of dollars.

News & Views

See all News and Views



  • New Jersey State Bar Association
  • Pennsylvania Bar Association
  • New York CPA (license is not active)



  • Pennsylvania
  • New Jersey


  • Rutgers, the State University of New Jersey at Camden, BS
  • Rutgers University School of Law, Camden, JD
  • Drexel University, MBA